Characterization of integrated BioPAT® Viamass for advanced perfusion process control in Ambr® 250 High Throughput Generation 2

Authors

• Ellen Lam, The Automation Partnership (Cambridge) Ltd, Sartorius Stedim, UKFollow
• Philipp Kaiser, Novartis Pharma AG, Basel, Switzerland
• Benjamin Sommer, Novartis Pharma AG, Basel, Switzerland
• Frederic Houioua, Novartis Pharma AG, Basel, Switzerland
• Barney Zoro, Sartorius Stedim Biotech Group (The Automation Partnership Limited), Royston, England

Conference Dates

October 5-9, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Ellen Lam, Philipp Kaiser, Benjamin Sommer, Frederic Houioua, and Barney Zoro, "Characterization of integrated BioPAT® Viamass for advanced perfusion process control in Ambr® 250 High Throughput Generation 2" in "Integrated Continuous Biomanufacturing VII (ICB VII)", Irina Ramos, AstraZeneca; Mark Brower, Merck; Alois Jungbauer, BOKU; K. Brower, Sanofi Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/biomanufact_vii/14